Title:
PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING COLON CANCER, CONTAINING EXTRACT OF TELECTADIUM
DONGNAIENSE AS ACTIVE INGREDIENT
Document Type and Number:
WIPO Patent Application WO/2017/222252
Kind Code:
A1
Abstract:
The present application relates to a pharmaceutical composition and a health functional food for preventing and treating colon cancer, containing an extract of Telectadium
dongnaiense as an active ingredient. The extract targets the Wnt/β-catenin signaling pathway, thereby being usable as a treatment for cancer caused by an abnormality of the Wnt signaling pathway or as an anti-cancer adjuvant.
Inventors:
LEE SANG KOOK (KR)
PARK HYEN JOO (KR)
KIM WON KYUNG (KR)
TRAN THE BACH (VN)
DO VAN HAI (VN)
BUI HONG QUANG (VN)
EUM SANG MI (KR)
CHOI SANGHO (KR)
LEE SANG WOO (KR)
LEE CHANGYOUNG (KR)
LEE JOONGKU (KR)
PARK SANG-HONG (KR)
PARK HYEN JOO (KR)
KIM WON KYUNG (KR)
TRAN THE BACH (VN)
DO VAN HAI (VN)
BUI HONG QUANG (VN)
EUM SANG MI (KR)
CHOI SANGHO (KR)
LEE SANG WOO (KR)
LEE CHANGYOUNG (KR)
LEE JOONGKU (KR)
PARK SANG-HONG (KR)
Application Number:
PCT/KR2017/006376
Publication Date:
December 28, 2017
Filing Date:
June 19, 2017
Export Citation:
Assignee:
SEOUL NAT UNIV R&DB FOUNDATION (KR)
KOREA RES INST BIOSCIENCE & BIOTECHNOLOGY (KR)
KOREA RES INST BIOSCIENCE & BIOTECHNOLOGY (KR)
International Classes:
A61K36/24; A23L33/105
Domestic Patent References:
| WO2014128142A1 | 2014-08-28 |
Foreign References:
| KR20150037024A | 2015-04-08 | |||
| KR20030016774A | 2003-03-03 | |||
| KR20080014326A | 2008-02-14 |
Other References:
CHOI SO JIN ET AL.: "Screening of herbal medicines from Vietnam with inhibitory activity on advanced glycation end products formation", KOREAN JOURNAL OF PHARMACOGNOSY, vol. 46, no. 3, 2015, pages 268 - 278, XP053034980
KIM, WON KYUNG: "P7-26) Antiproliferative activity of Telectadium dongnaiense and its constituents via inhibition of the Wnt/13-catenin signaling in human colon cancer cells", INTERNATIONAL CONFERENCE ON 70TH ANNIVERSARY OF THE PHARMACEUTICAL SOCIETY OF KOREA, 18 October 2016 (2016-10-18) - 20 October 2016 (2016-10-20), Seoul
KIM, WK: "Antitumor activity of periplocin, isolated from Telectadium dongnaiense, in colorectal cancer cells via suppression of Wnt/beta-catenin signaling", PLANTA MEDICA, vol. 82, no. s01, 14 December 2016 (2016-12-14), XP055601289, DOI: 10.1055/s-0036-1596587
KIM, WON KYUNG: "P7-26) Antiproliferative activity of Telectadium dongnaiense and its constituents via inhibition of the Wnt/13-catenin signaling in human colon cancer cells", INTERNATIONAL CONFERENCE ON 70TH ANNIVERSARY OF THE PHARMACEUTICAL SOCIETY OF KOREA, 18 October 2016 (2016-10-18) - 20 October 2016 (2016-10-20), Seoul
KIM, WK: "Antitumor activity of periplocin, isolated from Telectadium dongnaiense, in colorectal cancer cells via suppression of Wnt/beta-catenin signaling", PLANTA MEDICA, vol. 82, no. s01, 14 December 2016 (2016-12-14), XP055601289, DOI: 10.1055/s-0036-1596587
Attorney, Agent or Firm:
PARK, Weonmee (KR)
Download PDF:
Previous Patent: MACHINING CENTER CONTROLLING METHOD
Next Patent: FUEL CELL SYSTEM COMPRISING HEAT EXCHANGER USING ANODE GAS OR ANODE EXHAUST GAS
Next Patent: FUEL CELL SYSTEM COMPRISING HEAT EXCHANGER USING ANODE GAS OR ANODE EXHAUST GAS